HS-20117

· Hansoh BioMedical R&D Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HS-20117, covering 2025-04-09 to 2025-08-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung Cancer [Phase 2, Phase 3]

See pricing